Andrew David Levin
First SEC filing: Aug. 9, 2021 · Latest: June 12, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 11, 2026 | VOR | A | 57,162 | · | · | 57,162 Direct | · | Acquired | (price as of 2026-10-02) |
| June 5, 2026 | CLYM | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 18, 2025 | VOR | A | 3,000 | · | · | 3,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 4, 2025 | CLYM | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 26, 2024 | CLYM | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 18, 2023 | CLYM | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 19, 2022 | CLYM | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 9, 2021 | CLYM | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 11, 2026 | VOR | Stock option (right to buy) | Common stock | $14.09 | June 10, 2036 | 57,162 | Acquired |
| June 5, 2026 | CLYM | Stock Option (Right to Buy) | Common Stock | $10.55 | June 4, 2036 | 40,000 | Acquired |
| Dec. 18, 2025 | VOR | Stock Option (Right to Buy) | Common Stock | $12.80 | Dec. 17, 2035 | 3,000 | Acquired |
| June 4, 2025 | CLYM | Stock Option (Right to Buy) | Common Stock | $1.29 | June 3, 2035 | 40,000 | Acquired |
| June 26, 2024 | CLYM | Stock Option (Right To Buy) | Common Stock | $7.89 | June 25, 2034 | 10,000 | Acquired |
| May 18, 2023 | CLYM | Stock Option (Right To Buy) | Common Stock | $3.00 | May 17, 2033 | 10,000 | Acquired |
| May 19, 2022 | CLYM | Stock Option (Right to Buy) | Common Stock | $3.46 | May 18, 2032 | 10,000 | Acquired |
| Aug. 9, 2021 | CLYM | Stock Option (Right to Buy) | Common Stock | $12.50 | Aug. 8, 2031 | 20,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 9, 2021 | CLYM | No securities are beneficially owned. | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | · | · | · | · | · | · | $60,583 | $124,205 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.